Skip to main content

Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

Feedback
Newsletter
RSS
Twitter

User Top Menu

Welcome, guest
Log In
Join
Why Join?

Search form

Search

About Us
- Overview
- Who We Are
- Contact
- Fan Mail
- How to Cite
News & Future Directions
Papers
Forums
- Discussions
- Webinars
Professional Resources
Research Resources
Click Here to Support MSDF

You are here

Most Viewed

Immunopathogenesis of MS
Stopping Natalizumab May Increase Risk of MS Relapse
Antigen-Specific Therapy for MS Passes Safety Test
NMDA Receptors May Modulate Severity of Multiple Sclerosis
Refined Animal Model Led to Phenytoin Clinical Trial
Physical Activity Associated With Improved Quality of Life in People With MS
Corpus Callosum Cross-Section Correlated With Cognitive Decline
Human Brain and Spinal Fluid Resource Center
PodBlog: B-Cell Double Header
Fatigue in MS Linked to Elevated Body Temperature
Where There’s Smoke (and Stress), Is There Fire?
Interferon β and Glatiramer Acetate Are Clinically Similar, Says Cochrane Meta-Analysis
MS Patient, Ph.D.: Calling Dr. Thomas Hale
Coriell Cell Repositories
Tracking Remyelination: Do You See What I See?
Corticosteroids Ineffective for Many With Relapsing MS
BGC20-0134
MS Research Roundup: July 11, 2014
MS Patient, Ph.D.: Is It Too Early to Get Excited About the BCG Vaccine?
Phenytoin
Genome-wide Study Brings MS Landscape Into Sharper Focus
Researchers Spill the Beans
MIS416
Neuromyelitis Optica, Part 3: Treatment and Prevention
PML Death Associated With Tecfidera; FDA Issues Warning

Pages

« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »

MSDF Footer

Copyright © 2014 MGH and ACP

Privacy
Terms of Use
How to Cite
FAQ/Help
Site Map
Support Us
Feedback
Image Credits

All site content, except where otherwise noted, is licensed under a Creative Commons BY license. Please let us know where and how you use MSDF material.

Content By

Software By